|
 |
| Patents are often discussed
in a mythical world where a single inventor obtains the only patent on a
product. This newsletter issue explores the more complex worlds of
software, semiconductors and biotech where each product may involve hundreds
of patents. This complexity gives rise to a number of related problems often referred to as “patent thickets.” |
 |
 |
One problem arises when competing firms potentially
infringe each other's patents. James Bessen argues that when
competing firms aggressively build large patent portfolios, incentives
to perform R&D may be reduced. However, high patentability standards
may correct this problem. |
|
Evidence of this kind of strategic patenting
is found with software patents by James Bessen and Robert M. Hunt. Firms
in some industries have acquired large numbers of software patents and
the investment these firms make in R&D appears to have declined, relatively,
rather than to have increased. |
 |
Another problem, called the “anti-commons” by Michael Heller
and Rebecca Eisenberg, occurs when firms have to negotiate with many owners
to obtain needed technologies. Transaction costs may inhibit firms from
using innovative technologies. Rosemarie Ziedonis finds empirical evidence
of the effects of fragmented ownership in the semiconductor industry. |
 |
John Walsh, Wesley Cohen and Ashish Arora report survey evidence on
the extent to which licensing has restricted access to research tools
needed for biomedical research. They report that access to research tools
has not been a problem in some areas of biotech because researchers have
found “working solutions” around the anti-commons. But this is
partly because many university researchers have mistakenly assumed that they are
exempt from patent infringement. |
 |
Rebecca Eisenberg and Arti Rai propose a modest policy change that
may alleviate some of the problems of access to research tools. Currently,
the Bayh-Dole act gives universities control over how research results
are patented and licensed. But the universities do not necessarily act
in the public interest. Eisenberg
and Rai suggest that the agencies that fund the research should have
more say over licensing terms. |
 |
Oren Bar-Gill and Gideon Parchomovsky point out another mechanism that may help some anti-commons problems. When innovation is cumulative, some researchers may prefer to publish rather than patent some of their findings. This is because follow-on inventors will then
have greater incentives to improve the technology, possibly enhancing
the profits on the original invention. Bar-Gill and Parchomovsky suggest policy changes
to encourage publication. |
| |